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Abstract
The effects of changes in the steady level of diastolic blood pressure on fluid
flux across the jejunum has been investigated in the anesthetized rat during
perfusion with a nutrient-free and Na+-free solution. Diastolic blood pressure
was manipulated by intravenous infusions, during the jejunal perfusions, of
vasodilators (vasoactive intestinal polypeptide, acetyl-b-methylcholine, and
phentolamine) and a vasoconstrictor (arginine vasopressin), each of which
acts through a different cellular mechanism. The outcome was that fluid flux
was related by a parabolic relationship with diastolic blood pressure in which
net secretion occurred over the range 40–100 mmHg, whereas net absorption
was recorded at diastolic pressures exceeding 100 mmHg and below
40 mmHg. Against a background of normal absorption promoted by perfu-
sion with 145 mmol L1 Na+/5 mmol L1 glucose solution, reductions in dia-
stolic blood pressure markedly reduced the mean rate of fluid absorption by
58% overall, whereas the rate of glucose absorption remained unchanged. Our
results were explained on the basis that vasodilatation led to increased capil-
lary pressure and then to net filtration of fluid from the mesenteric capillary
bed. Experiments in which Escherichia coli heat-stable toxin was added to the
jejunal perfusate confirmed the absence of a secretory response, which was
consistent with the absence of effect of the toxin on diastolic blood pressure.
Introduction
The prevailing view of small intestinal secretion has been
that the crypts of Lieberk€uhn secrete a solution of Na+,
Cl, and HCO3 , whereas absorption occurs at the villi,
thus forming an external fluid circuit (Gregory 1962). This
separation of function has received considerable support
from experiments on intestinal mucosa in which selective
inactivation of the crypts did not impair the absorptive
function of the villi, whereas inactivation of the villi was
without effect on fluid secretion by the crypts (Serebro
et al. 1969; Roggin et al. 1972). The processes underlying
crypt cell secretion were subsequently investigated by
Huott et al. (1988) who showed that, as a consequence of
low intracellular Na+ through the action of the basolateral
Na+/K+ ATPase, Na+ entry drives the basolateral Na+/K+/
2Cl cotransporter to effect K+ and Cl entry. K+ ion is
recycled through the basolateral K+ conductance, whereas
the elevated intracellular Cl concentration causes the
efflux of Cl ion through the luminal CFTR (cystic fibro-
sis transmembrane conductance regulator) into the lumen
of the crypt. Cl ion flux is thus regarded as the driving
force for the accompanying secretion of Na+ and water
(Barrett and Keely 2000). However, the preparation used
by Huott et al. (1988) which consisted of monolayers
derived from metastatic colonic carcinoma cells may not
be entirely representative of normal function as perfused
colonic crypts have been shown to be absorptive in func-
tion rather than secretory and that secretions were evoked
only on stimulation by an agonist (Singh et al. 1995).
Overall, the small intestine in the basal state shows net
absorption as indicated by the positive mucosal to serosal
flux of Na+ and Cl ion (Love 1969; Field et al. 1972;
Guandalini et al. 1982). However, the extent to which
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agonists can reverse this absorption into net secretion is
important as it underpins the understanding of the debili-
tating secretory diarrhea caused by toxins from Vibrio
cholerae and Escherichia coli. The latter produces two
main toxins: a heat labile toxin producing cholera-like
responses and a heat-stable toxin which has been the sub-
ject of intensive investigation (Sach 1975). The fluid loss
into the lumen associated with these infections is said to
be driven primarily by increased Cl secretion through
the CFTR, which is then followed by Na+ and water
secretion. With respect to V. cholerae, the CFTR is acti-
vated by increased levels of cAMP produced by stimula-
tion of adenylate cyclase by cholera toxin (Chen et al.
1971; Field et al. 1972; Burleigh & Borman, 1997),
whereas E. coli heat-stable toxin acts by increasing cGMP
levels through activation of guanylate cyclase (Field et al.
1978; Giannella and Drake 1979; Rao et al. 1981; Guanda-
lini et al. 1982). Even though both toxins cause consider-
able fluid loss from the intestine of infected humans
(Sach 2011), inconsistencies have arisen in the results
from experimental studies on animal models. Net Cl
secretion which is associated with increased negativity of
the transmucosal short circuit current (Isc) has been dem-
onstrated after luminal exposure to V. cholerae toxin both
in vitro and in vivo (Love 1969; Field et al. 1972; Krejs
et al. 1978) though, by contrast, this was not shown by
Norris et al. (1967) who reported that Isc remained con-
stant after 6 h of choleragen-induced fluid secretion
in vivo nor by Moritz et al. (1972) who showed an
absence of net Cl despite marked fluid secretion. For
E. coli toxin-induced fluid loss, the position is also
unclear as the basal Cl flux in the absorptive direction
does fall to zero after exposure to toxin but does not
reverse into net secretion (Field et al. 1978; Rao et al.
1981; Vaandrager et al. 2000), though Guandalini et al.
(1982) have reported a full reversal from net absorption
to net Cl secretion. The time courses of action also dif-
fer very markedly. E. coli toxin acts remarkably rapidly
(Evans et al. 1973; Field et al. 1978; Giannella and Drake
1979; Guandalini et al. 1982; Huott et al. 1988), whereas
V. cholerae toxin has a much slower time-course of action
extending into hours (Field et al. 1972; Evans et al. 1973;
Carey and Cooke 1986; Petritsch et al. 1992; Burleigh and
Borman 1997), which has been explained by the delayed
penetration of the toxin into the mucosal cells (Burleigh
and Borman 1997). A marked lack of consistency also
becomes apparent when relating the results obtained in
vitro to those obtained in vivo. Experimental studies in
both humans and animals have shown that V. cholerae
toxin consistently caused copious intestinal secretions
(Benyajati 1966; Norris et al. 1967; Carpenter et al. 1969;
Love 1969; Moritz et al. 1972; Evans et al. 1973; Sach
et al. 1976; Krejs et al. 1978; Petritsch et al. 1992). By
contrast, the position regarding E. coli heat-stable toxin is
less clear. There are instances in which net secretion has
been reported (Evans et al. 1973; Vaandrager et al. 2000)
though, in other studies, no significant net secretion was
recorded (Sach et al. 1976; Rolfe and Levin 1994; Lucas
et al. 2005, 2008, 2011). As there are disparities in terms
of Cl ion secretion, latency of action and the amount of
net fluid secretion between two major effectors of secre-
tory diarrhea, viz. V. cholerae and E. coli toxins, there are
compelling reasons to investigate whether there are other
mechanisms aside from Cl ion secretion which promote
intestinal fluid secretion.
Our approach to this problem has involved a consider-
ation of mucosal blood pressure, which stems from the
observation of Claude Bernard in 1859 (in Gregory 1962),
and confirmed by Gregory (1947), that denervation of the
small intestine in vivo leads to copious intestinal secre-
tions (paralytic secretion). As denervation, particularly
extirpation of the coeliac ganglion as in the case of
Claude Bernard, must inevitably affect the pressure within
the mucosal vasculature, we have sought to investigate
the extent to which intestinal fluid movement is affected
by the prevailing arterial blood pressure (ABP) in condi-
tions in which intestinal absorption was minimized by
use of a Na+-free and nutrient-free perfusate. Manipula-
tion of the peripheral resistance of the vasculature was
achieved by intravenous (I.V.) infusions of vasoactive
agents over the duration of the perfusion of the jejunum.
A depressor action through vasodilatation was mediated
with (1) vasoactive intestinal polypeptide (VIP), the neu-
rotransmitter form of secretin, which through receptor
binding activates adenylate cyclase to cause cAMP pro-
duction, activation of PKA and phosphorylation of myo-
sin light chain kinase (F€olsch et al. 1980; Kamm and Stull
1985), (2) acetyl-b-methylcholine (MC), a stable analog
of acetylcholine, which binds to muscarinic receptors to
activate phospholipase C to cause an elevation of intracel-
lular IP3 and intracellular Ca
2+, subsequent activation of
nitric oxide synthase leading to NO production (Eglen
2005), and (3) phentolamine which blocks a-adrenocep-
tors preventing the pressor action of catecholamines,
which are mediated through elevation of intracellular IP3
and intracellular Ca2+ (Bylund et al. 1994). A pressor
action was mediated by infusion of arginine vasopressin
(AVP) acting on V1 receptors causing an elevation of
intracellular IP3 and intracellular Ca
2+ to cause smooth
muscle contraction (Thibonnier et al. 2001). The outcome
of these experiments was that there was clear evidence of
intestinal secretion, but only when the diastolic blood
pressure (DBP) fell within the range 40–100 mmHg with
absorption occurring above and below this range. As a
possible explanation for this result is that vasodilatation
leads to increased mucosal capillary pressure which, in
2015 | Vol. 3 | Iss. 5 | e12407
Page 2
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
Intestinal Fluid Secretion M. L. Lucas & J. D. Morrison
turn, leads to increased capillary filtration of fluid and
hence secretion, we have also sought to investigate its
plausibility by devising a pressure/flow model using estab-
lished cardiovascular values.
Methods
Experiments were carried out on male rats of 250–400 g in
accordance with the Animals (Scientific Procedures) Act
1986. The animals were fasted overnight but were allowed a
5% sucrose drink in addition to water. They were anesthe-
tized with an intraperitoneal (I.P.) injection of pentobarbi-
tone sodium (Rho^ne Merieux, Harlow, U.K.) at a dose of
80 mg kg1. The criterion for anesthesia was abolition of
the hind limb flexor withdrawal reflex. In order to maintain
the level of anesthesia, supplementary I.P. injections
(24 mg kg1) were given as required. At the end of the
experiments, the animals were killed with an I.V. injection
of 100 mg Euthatal (Merial Animal Health, Harlow, UK).
Surgical procedures
The surgical procedures consisted of the following: tra-
cheostomy to allow tracheal aspiration and artificial venti-
lation if necessary, cannulation of the carotid artery to
monitor the ABP, cannulation of the external jugular vein
and occasionally the external iliac vein for slow infusions
(Portex cannulae of outer diameter 1.0 mm and contain-
ing heparinized saline at 100 I.U. heparin mL1, Leo
Laboratories Ltd., Princes Risborough, UK) and bilateral
vagotomy to abolish vago-vagal reflexes. Following a mid-
line incision of the abdominal wall, the pyloroduodenal
junction was ligated to prevent entry of gastric secretions
into the duodenum and the small intestine was exposed.
Cannulae of 4.0 mm outer diameter were inserted and
tied in at both ends of a 30 cm length of jejunum located
distal to the ligament of Treitz. The animal’s temperature
was maintained as near as possible to 37°C and at the
end of the experiment, the length of the perfused jejunal
loop was measured and a sample taken for histology.
Experimental procedure
The warmed perfusate was circulated by a Watson–Marlow
peristaltic pump at a rate of 1.0 mL min1 from a 50 mL
measuring cylinder standing in a heated water bath through
polythene tubing of internal diameter 3.0 mm into the jeju-
nal loop in situ from which the effluent was then returned
by another length of tubing to the measuring cylinder.
First, the jejunum was flushed through with 25 mL of
154 mmol L1 choline chloride solution (Sigma C1879;
Sigma, Poole, UK) and the perfusate discarded. The experi-
mental perfusate consisted of 40.0 mL 154 mmol L1 cho-
line chloride solution containing 100 lmol L1 EIPA (5-
(N-Ethyl-N-isopropyl) amiloride: Sigma A3085; Sigma)
(Na+/H+ antiport antagonist) at 37°C and pH 7.0, which
was recirculated from the measuring cylinder standing in
the water bath for a timed period of at least 1 h after which
the perfused fluid was then recovered from the jejunal loop
and any change in the amount of perfusate was determined
as the difference in the weight of fluid before and after per-
fusion. Steady reductions in peripheral resistance, indicated
by the systemic blood pressure recordings, were achieved
by slow I.V. infusions over 45–60 min using a micrometer-
driven syringe of either 10–50 lg VIP (Sigma V6130;
Sigma) or 100–300 lg acetyl-b-methylcholine bromide
(Sigma A2126; Sigma) dissolved in 1.5 mL isotonic saline,
whereas 200–500 lg phentolamine mesylate (Rogitine,
Ciba, Basel, Switzerland) was injected by slow bolus injec-
tion in 0.2 mL isotonic saline. Increases in peripheral resis-
tance were achieved by slow I.V. infusions of 2.5–8.0 lg
arginine vasopressin (Pitressin, Parke-Davis, Pontypool,
UK) also dissolved in 1.5 mL isotonic saline. In addition,
further experiments were undertaken involving the perfu-
sion of the jejunum with Krebs-phosphate solution con-
taining 145 mmol L1 Na+ and 5.0 mmol L1 glucose pH
7.4 in order to promote absorption. In one set of experi-
ments, the effects of the vasodilator agents I.V. on fluid
absorption, measured by the method described above, and
on glucose absorption, measured in duplicate with the
Accu-Chek glucose meter (Roche Diagnostics, Burgess Hill,
UK), were determined. In the second set of experiments,
the effect of the addition of 1.0 lg E. coli heat-stable toxin
(STa) (Sigma E-5763; Sigma) to the luminal perfusate was
tested.
Histology
After completion of the experiments, a 5 cm length of the
perfused jejunum was infused with 10% formal saline and
immersed in 10% formal saline overnight and then pro-
cessed for paraffin embedding. Transverse sections were
made from several locations in each segment of gut and
stained with hematoxylin/eosin and alcian blue for light
microscopy.
Data analysis
Application of the appropriate statistical tests was made
with Minitab 15 (Minitab UK, Coventry, UK). Compari-
sons against zero were made with the t-test, comparisons
of changes in ABP and heart rate were made with the
paired t-test and the coefficient of determination (R2) was
obtained by regression analysis, with statistical signifi-
cance taken as P < 0.05. The results throughout are
expressed as the mean  SEM.
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Results
Arterial blood pressure
The results were obtained from a total of 39 rats in which
the ABP at the commencement of the experiments had
the mean values of 132/104 mmHg with a mean ABP of
114  2.0 mmHg, a pulse pressure of 28  1.0 mmHg
and a heart rate of 388  5 bpm (beats per minute).
While many experiments ended with the infusion of a
vasoactive agent, in nine animals a second control perfu-
sion was undertaken. In these cases, after 4–5 h, the mean
ABP of 116  3.6 mmHg and the pulse pressure of
27  2.1 mmHg were unchanged compared with the
starting values (P = 0.41). There were also no adverse
effects of perfusion of the jejunum with 154 mmol L1
choline chloride and 100 lmol L1 EIPA when these were
perfused as an initial control procedure in 10 animals
(Fig. 1A): the DBP after perfusion for 1 h
(110  3.7 mmHg) was not significantly different from
that at commencement of perfusion (113  5.1 mmHg)
(P = 0.40).
During the jejunal infusions, the diastolic blood pres-
sures through I.V. infusion of vasoactive agents ranged
from 128 mmHg during AVP infusion down to as low as
20 mmHg with continuous I.V infusion of VIP and MC
and with a single bolus injection of phentolamine which
caused sustained reductions (Fig. 1B–D). Initially, MC
caused a transient reduction in heart rate to 30–50% of
the control value with an associated increase in pulse
pressure, both of which rapidly subsided, presumably due
to desensitization of the cardiac muscarinic receptors. The
effects of the vasoactive agents on cardiac function during
the period of I.V. infusion were assessed after the DBP
had reached a steady state. Compared with the control
value for each animal, neither MC nor phentolamine sig-
nificantly affected heart rate or pulse pressure (P > 0.20).
The pulse pressure remained unchanged with VIP
(P = 0.64) though there was a small, but significant
reduction in heart rate by 26  7 bpm (6%) (P = 0.006).
While these results indicate a degree of constancy of car-
diac function, this was not the case with AVP which sig-
nificantly increased pulse pressure by 26  7.0 mmHg
(100%) (P < 0.001) and was associated with a significant
reduction in heart rate by 58  7 bpm (15%) (P < 0.01).
Jejunal fluid flux
For the 13 control perfusions, the amount of fluid
secreted (denoted +) or absorbed (denoted ) by the
jejunal loop did not seem, at first sight, to follow a con-
sistent pattern with a nonsignificant mean value of
0.4  4.8 lL cm1 h1 (P = 0.94). However, further
analysis showed a significant inverse relationship between
net fluid flux and the DBP (R2 = 65%, Pslope = 0.001),
such that net secretion was recorded for blood pressures
of <100 mmHg and net absorption was recorded for
blood pressures of >100 mmHg (Fig. 2, open circles).
The outcome was the same when the mean ABP was used
in place of DBP.
When the results for the four vasoactive agents were
included, now giving a total of 52 results, a definite pat-
tern emerged in the form of a highly significant parabo-
loid relationship between flux rate and DBP (R2 = 72%,
P < 0.001) (Fig. 2). Over the range of DBP of 135 to
100 mmHg (AVP and control results), net absorption was
A B
C D
Figure 1. Arterial blood pressure traces from four different animals during jejunal perfusions with 154 mmol L1 choline chloride and EIPA
showing: (A) Control recording without I.V. infusion. (B) Slow infusion of 50 lg VIP I.V. (VIP). (C) Slow infusion of 300 lg acetyl-b-
methylcholine I.V. (MC). (D) I.V. injection of 0.5 mg Phentolamine (Phen). The dashed horizontal line denotes 0 mmHg. The disturbance in
trace D was caused by flushing of the arterial cannula.
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recorded, whereas over the range 100 to 40 mmHg (VIP,
MC, phentolamine, and some control results), net secre-
tion as high as +60 lL cm1 h1 occurred. Finally, at
DBP of <40 mmHg (MC and phentolamine), absorption
of increasing magnitude was recorded. A similar relation-
ship with that shown in Figure 2 was obtained when the
rate of fluid flux was related to the mean ABP
(R2 = 66%, P < 0.001).
Coinfusion of vasoactive agents
The basis of the coinfusion experiments was to use infu-
sion of AVP into the jugular vein to nullify the action of
the vasodilator infused into the external iliac vein in
order to maintain a steady ABP. When infused alone,
AVP elevated the DBP to 127  1.1 mmHg which was
associated with a significant net absorption rate of
20  2.5 lL cm1 h1 (P = 0.001) (5 experiments). By
contrast, VIP infusion (13 experiments) resulted in a sig-
nificant fall in DBP to 62  5.8 mmHg which was associ-
ated with net secretion at a significant rate of
+20.9  5.5 lL cm1 h1 (P = 0.003). When AVP and
VIP were coinfused in four experiments (Fig. 3), the DBP
was maintained at 106  2.4 mmHg, whereas the secre-
tion rate, instead of being zero as might have been
expected from Figure 2, was significantly elevated at
+20.6  2.33 lL cm1 h1 (P = 0.003) (Fig. 2, inverted
solid triangles). These results thus indicate that VIP still
caused net secretion when the ABP was maintained at a
normal value. In two further experiments to test the tol-
erance to low DBP, AVP was infused subsequent to an
injection of phentolamine which had reduced the DBP to
25 mmHg and had caused a mean absorption rate of
12 lL cm1 h1. In both cases, AVP restored the DBP
to 70 mmHg and absorption was transformed into secre-
tion at a mean rate of +21 lL cm1 h1. This indicated
that secretion could be restored even after the jejunum
had been subjected to an extended period of low DBP.
This was further supported by the normal histological
appearance of the mucosa under light microscopy as
shown in Figure 4. Routine histology confirmed the
Figure 2. Magnitude of rate of secretion (positive values) and
absorption (negative values) for the perfused jejunal loop in vivo at
different prevailing levels of diastolic blood pressure caused by
vasoactive agents I.V. denoted by the different symbols. The
numbers in parentheses show the number of observations. The
continuous curve follows the equation y = 0.00012x3 
0.040x2 + 3.7x – 80, whereas the dashed curves show the upper
and lower 95% Confidence Interval for the regression curve.
A B
C D
Figure 3. Arterial blood pressure traces from a sequence of procedures in the same animal during jejunal perfusions with 154 mmol L1
choline chloride and EIPA: (A) Control recording without I.V. infusion with an absorption rate of 8.8 lL cm1 h1 at a DBP of 118 mmHg. (B)
Slow coinfusion of 50 lg VIP I.V. and 3 lg AVP I.V. with a secretion rate of +17.8 lL cm1 h1 at a DBP of 112 mmHg. (C) Slow infusion of
50 lg VIP I.V. with secretion rate of +26.0 lL cm1 h1 at a DBP of 62 mmHg. D. Control recording without I.V. infusion with an absorption
rate of 5.0 lL cm1 h1 at a DBP of 104 mmHg. In B, the VIP infusion caused an initial dip in blood pressure which was restored to normal
with the commencement of AVP infusion. In C, the marked fall in blood pressure marks the start of VIP infusion. The dashed horizontal line
denotes 0 mmHg.
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integrity of the jejunal mucosa in all experimental prepa-
rations.
Effects of reduced DBP on normal
absorption
The effects of reduced DBP produced by I.V. infusion of
VIP, MC or phentolamine on normal absorption, which
was enabled by perfusion of the jejunum with
150 mmol L1 Na+/5.0 mmol L1 glucose Krebs solution,
was determined in nine animals. Each jejunal perfusion at
a reduced DBP was paired with a perfusion at normal
DBP and the results are summarized in Table 1. There
was, in every case, a marked reduction in the rate of
absorption from the control value (Fig. 5, open circles) to
the test value when the DBP was reduced (Fig. 5, special
symbols). The rate of absorption and DBP showed a sig-
nificant parabolic relationship, shown by the solid curve,
similar to that in Figure 2, shown by the dashed curve,
though with downward shift and a reduced goodness of
fit (R2 = 53%, P = 0.004). Overall, the mean control rate
of 97 lL cm1 h1 was significantly reduced by 58% to
41 lL cm1 h1 when the DBP was reduced
(P < 0.001) (Table 1). Of special note was that the rate
of glucose absorption remained constant when the DBP
was reduced (P = 0.78).
These results thus demonstrate the effectiveness of
reduced DBP in markedly reducing the rate of fluid
absorption in the presence of normal glucose absorption.
Discussion
In this study, it has been shown for the perfused jejunal
loop in vivo that, when the conditions for absorption are
removed viz. absence of glucose and Na+ (which was
replaced by the impermeant ion choline) and inhibition
of the Na+/H+ antiport by EIPA, net secretion was possi-
ble with rates as high as +60 lL cm1 h1. This net
secretion, however, very much depended on the prevailing
ABP such that net absorption occurred at high and low
DBPs, whereas net secretion occurred in the range
between 40 and 100 mmHg for the DBP (Fig. 2). So,
consequently, secretion could occur in the control condi-
tion, provided that the DBP erred toward lower values.
Small but significant levels of secretion have also been
recorded with choline chloride perfusion by Lee (1977)
and Lucas et al. (2005), though these cannot be related to
the ABP values which were not documented in these
studies.
In order to achieve an extended range of DBP values,
intervention was required in the form of I.V. infusion of
vasoactive agents. The three vasodilators which were used
(VIP, MC, and phentolamine) and the vasoconstrictor
Figure 4. Transverse section of jejunum with lumen at the top
after jejunal perfusion experiment with 154 mmol L1 choline
chloride and EIPA in which I.V. bolus injection of 1 mg
phentolamine reduced the DBP to 18 mmHg for 1 h. This was
followed by slow infusion of 10 lg AVP to restore the DBP to
70 mmHg for 1 h. Hematoxylin, eosin and alcian blue staining.
Figure 5. Magnitude of rate of secretion (positive values) and
absorption (negative values) for the jejunal loop in vivo perfused
with 145 mmol L1 Na+ and 5.0 mmol L1 glucose solution at
different prevailing levels of diastolic blood pressure caused by
vasoactive agents I.V. denoted by the different symbols. The
numbers in parentheses show the number of observations: some
experiments contained two test infusions. The continuous solid
curve follows the equation y = 0.0011x3  0.30x2 + 24x – 623,
whereas the dashed curve is reproduced from Figure 2.
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AVP each acts through a different cellular mechanism
(Introduction). Given that phentolamine has its actions
through its antagonism of the sympathetic neurotransmit-
ter noradrenaline, all four vasoactive agents have been
shown to act on the mesenteric vasculature, including the
villous arcade, predominantly through actions on the
arterial vasculature thus affecting inflow into the mesen-
teric capillary beds (Dresel and Wallentin 1966; Krejs
et al. 1978; Hollinger et al. 1983; Tesfamariam and Halp-
ern 1987; Warner 1990). As shown by Figure 2, net jeju-
nal secretion was not associated with a specific vasoactive
agent but, rather, was dependent upon the DBP caused
by that vasoactive agent so that secretion occurred over
the range from 100 mmHg down to 40 mmHg. By con-
trast, DBP values above 100 mmHg and below 40 mmHg
were associated with net absorption of fluid. An impor-
tant consideration is the reliance which can be placed
upon the results obtained from our experiments. As
confirmation of the animal’s physiological condition, in
those experiments which ended with a control perfusion,
the animals still maintained a normal ABP after 4–5 h
experimentation. Additionally, perfusion of the jejunum
with 154 mmol L1 choline chloride was without an
adverse effect per se on the DBP, and histological exami-
nation of the jejunum after each experiment showed nor-
mal mucosal structure under light microscopy. The
robust nature of the results was additionally confirmed by
interleaving different interventions in the same animal.
So, for example, two periods of net secretion during VIP
infusion were then followed by net absorption when the
DBP was allowed, on cessation of the VIP infusion, to
return to its control value (Fig. 3 and legend). The con-
verse result was also obtained when a period of net
absorption at reduced DBP values was then followed by
net secretion when the DBP was subsequently increased
to a new steady level. In these cases, the jejunal mucosa
still showed a normal appearance under light microscopy
(Fig. 4). Throughout, we saw no indications of mucosal
cell shedding, as reported by Lee (1977) during exposure
to secretagogues, which is in accord with the normal
appearance of the ileum reported by Patnaik and Ghosh
(1966) after cholera-induced secretion.
While the results in Figure 2 indicate DAB to be a fac-
tor responsible for secretion, the possibility of a direct
secretagogue action of the agonists, possibly on the crypt
cells, needs to be examined as such a stimulatory action
has been claimed for both MC (Isaacs et al. 1976; Singh
et al. 1995) and VIP (Barbezat and Grossman 1971; Krejs
et al. 1978; Singh et al. 1995; Banks et al. 2005). In the
present study, MC caused secretion in only two experi-
ments, whereas absorption occurred in five experiments,
which is not what would be expected if MC were stimu-
lating the crypt cells directly. Even with our limited subset
of seven data points, fluid flux was highly significantly
inversely related to DBP (R2 = 80%, Pslope = 0.002), indi-
cating that DBP was the determining factor. The results
for VIP infusion which, overall, caused appreciable net
secretion were the subject of further investigation. When,
while VIP was being infused I.V., simultaneous infusion
of AVP was undertaken to neutralize the anticipated fall
in ABP (Fig. 3B), an appreciable level of secretion of
+20.6  2.33 lL cm1 h1 (P = 0.003) still occurred
(Fig. 2, solid triangles). This may indicate an ABP-inde-
pendent action of VIP in the form of an effect on the
crypts as suggested by results from the Thiry-Vella loop
preparation in conscious dogs (Barbezat and Grossman
1971), perfused jejunal loops in anesthetized dogs (Krejs
et al. 1978) and perfused colonic crypts (Singh et al.
1995). However, it would also be consistent with elevated
capillary pressure despite normal ABP or an increase in
the capillary filtration coefficient.
The reason for the dependence of fluid flux across the
jejunum on ABP may stem from the consequences that
the prevailing systemic ABP has on the blood flow in the
mucosal capillary bed. In the normal state, the major fall
in pressure occurs across the arterioles so that blood
enters the capillary bed at a relatively low nonpulsatile
pressure. At this point, due to the high permeability of
the capillary vessel walls, the Starling forces have their
action so that the hydrostatic pressure drives fluid out of
the capillaries and the plasma protein oncotic pressure
draws fluid into the capillaries. The traditional view is
that, at the arteriolar end of the capillary bed, the excess
of hydrostatic pressure over oncotic pressure results in
net filtration out of the capillaries into the interstitial
fluid, whereas at the venular end of the capillary bed, the
hydrostatic pressure falls to below that of the oncotic
pressure, so that absorption of fluid occurs. However, this
Table 1. Effects of reduced diastolic blood pressure on normal absorption.
Normal Reduced DBP P
Diastolic blood pressure (mmHg) 106  1.4 50  3.9 P < 0.001
Fluid flux (lL cm1 h1) 97.2  7.6 41.3  9.7 P < 0.001
Glucose absorption (lmol cm1 h1) 1.6  0.14 1.7  0.32 P = 0.78
ª 2015 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
the American Physiological Society and The Physiological Society.
2015 | Vol. 3 | Iss. 5 | e12407
Page 7
M. L. Lucas & J. D. Morrison Intestinal Fluid Secretion
does not take into account the interstitial tissue pressure
which is slightly subatmospheric with the result that, in a
well perfused capillary bed, filtration occurs along the
entire length of the capillary bed with the exuded fluid
drained away by the lymphatic system (Levick 2003). This
is the situation which may be expected when the DBP is
positioned at 100 mmHg (Fig. 2). When there is systemic
vasoconstriction so that the DBP is in excess of
100 mmHg, as caused by AVP, this will lead to reduced
perfusion of the capillary bed and a reduction in the
hydrostatic pressure so that net absorption will arise from
the interstitial fluid which will, in turn, lead to absorption
through the mucosa from the lumen. Such a reduction in
pressure has been reported in mesenteric first-order arte-
rioles by Bohlen and Gore (1979) in response to sympa-
thetic nerve stimulation. The same outcome, viz. net
absorption, will also occur at DBP below 30–40 mmHg
but for a different reason: due to the severe reduction in
ABP resulting from the widespread vasodilatation caused
by the vasoactive agent, the blood flow through the capil-
lary bed will be reduced to such an extent that the hydro-
static pressure now falls so that net absorption again
occurs. This effect of stasis of the blood flow on capillary
hydrostatic pressure has been measured directly in frog
mesenteric capillaries by Landis (1926).
By contrast, over the range 40–100 mmHg, when the
vasodilatation is more modest, this would have the effect
of reducing the velocity of the blood flow in the mucosal
capillary bed with the consequence that the hydrostatic
pressure will increase. This is in keeping with Bernouilli’s
principle (Levick 2003) and is confirmed by direct mea-
surements in mesenteric capillaries in which dilatation led
to elevation of the pressure within individual capillaries
in frog by 3–4.5 mmHg (Landis 1927), while a 50%
reduction in arterial blood pressure resulted in a mean
increase in capillary pressure of 14 mmHg in cat (K€oniges
and Otto 1937). As a consequence of the increased hydro-
static pressure in the capillary bed, this will lead to
increased filtration of fluid from the capillary bed into
the interstitial fluid space within the villi and, then,
through the mucosal epithelium into the lumen. At a
DBP of 40 mmHg, the pressure into the capillary bed is
now so reduced that the capillary pressure declines pas-
sively with arterial pressure. The consequence is that out-
ward filtration is countered by absorption due to the
capillary oncotic pressure so that zero net flux results at
this pressure. With the simplification of setting the hydro-
static pressure and the oncotic pressure in the intestinal
lumen to zero, the main force for driving fluid into the
lumen will be the difference between capillary hydrostatic
and capillary oncotic pressure (see Appendix). As the
oncotic pressure is essentially constant, the dominant fac-
tor for filtration is thus the hydrostatic pressure and it is
this which increases when the DBP is reduced. The route
for the exuded fluid through the mucosa has been attrib-
uted to passage through the protein network of the tight
junctions located between adjoining enterocytes (DiBona
et al. 1974; Anderson and Van Itallie 1995), though pas-
sage through aquaporins (AQP6) which are concentrated
in the enterocytes at the villus tips also needs to be consid-
ered, though with the qualification that AQP6 appears to
be pH sensitive (Laforenza et al. 2009). With respect to the
proposed process of filtration through the intestinal
mucosa, there are previous studies in which venous pres-
sure has been increased and the plasma oncotic pressure
has been reduced. In both cases, the normal absorptive
function of the small intestine was reversed into fluid
secretion due to increased filtration from the capillary bed
(Lee 1973; Yablonski and Lifson 1976). There are also well
documented precedents of other epithelia which secrete
through ultrafiltration viz. the choroid plexus which
secretes cerebrospinal fluid (Pollay et al. 1983) and the cili-
ary epithelium of the eye which secretes 20% of the aque-
ous humor production by this means (Davson 1990).
The rate of fluid absorption during perfusion with
Krebs solution containing Na+ and glucose occurred at
the high value of 97 lL cm1 h1 which is similar to
previously reported values for the rat (Humphreys and
Earley 1971; Lee 1973; Lucas et al. 2008; Morrison 2012).
When the DBP was reduced from its normal value of
106 mmHg down to a range extending from 72 to
22 mmHg, there was a dramatic reduction in the mean
rate of fluid absorption by 58% overall (Fig. 5, Table 1).
That this occurred while the rate of glucose absorption
remained unchanged indicated that the effect of the
reduced DBP occurred during the normal absorptive pro-
cess, which is consistent with the results of Serebro et al.
(1968) who showed that glucose absorption remained
constant during cholera-stimulated fluid secretion. If the
mean reduction in the rate of absorption by
56 lL cm1 h1 (Table 1) is taken to be the rate of fluid
secretion which is countering normal fluid absorption,
this amounts to three times the peak level of fluid secre-
tion apparent with the Na+-free/glucose-free perfusate
(Fig. 2). As glucose absorption must be accompanied by
Na+ absorption which, in turn, is followed by greater
fluid absorption (Schultz et al. 1974), a possible explana-
tion for the inferred higher rate of fluid secretion is that
the absorptive process is now providing more fluid for
the secretory process. While the secretion described with
Na+-free and glucose-free perfusate may be considered to
replicate the fasted gut, even in the presence of Na+ and
glucose such as is used in oral rehydration therapy, there
would still be a substantial action of reduced DBP in
reducing the rate of fluid absorption. It was also noted
that VIP infusion produced the greatest reductions in the
2015 | Vol. 3 | Iss. 5 | e12407
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rate of absorption, reducing it to zero in one case and
driving it into active secretion in a second case (Fig. 5).
This action of VIP through reducing ABP and possibly
increasing capillary pressure and permeability may con-
tribute substantially to the severe secretory diarrhea of
pancreatic cholera (Verner–Morrison syndrome) in which
VIPoma cells in the Islets secrete excessive quantities of
VIP into the circulation (Mansour and Chen 2004).
Formulation of a model
In order to test numerically the plausibility of our pro-
posal that reduced diastolic blood pressure results in
increased capillary pressure which then leads to fluid exu-
dation and secretion into the intestinal lumen, we have
formulated a model which is based on established cardio-
vascular values and on a number of simplifying assump-
tions. The capillary vessels are assumed to be of a
constant number, of a constant length and of a uniform
diameter and, when the diameter changes, it does so uni-
formly across the capillary bed. It is assumed that the vis-
cosity of the blood remains constant, and that the cardiac
output remains constant during infusion of the vasoactive
agents. The latter is not unreasonable given that, with the
exception of AVP, heart rate and pulse pressure remained
essentially unchanged during the I.V. infusions.
From the relationship
Arterial Blood Pressure ¼ Cardiac Output
 Peripheral Resistance;
the peripheral resistance into the arteriolar end of the




where 100 mmHg is the DBP (Wheeler et al. 2002;
McHarg et al. 2004), 22 mmHg is the pressure at the
arteriolar end of the mesenteric bed (Landis and Pappen-
heimer 1963), and 68 mL min1 is the cardiac output
(Slama et al. 2003). This gives a value for the peripheral
resistance of 1.15 units. Then, the value for the blood ves-
sel radius (r) expressed in relative units was incremented
from 0.90 at DBP = 125 mmHg to 1.92 at DBP =
10 mmHg (as shown in Fig. 6A). These values are well
within the range recorded from mesenteric arterial
branches after denervation or during various levels of
transmural stimulation of sympathetic nerves (Bohlen and
Gore 1977; Tesfamariam and Halpern 1987).
Then, using r4 as a simplification of Poiseuille’s
expression for resistance, the hydrostatic pressure at the





Figure 6. (A) Relative values allocated for arteriolar radius against
diastolic pressure referenced against a value of 1.00 at 100 mmHg.
(B) Calculated values of capillary pressure at different diastolic
pressure values using the radius values in A with the horizontal
dashed line showing 22 mmHg. (C) Calculated values for net fluid
flux across the mesenteric capillary bed in response to reducing
levels of diastolic blood pressure (continuous curve), showing data
points from Figure 2 as open circles but excludes coinfusions of VIP
and AVP. Further details are given in the text.
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Capillary pressure ¼ DBP 68mLmin1  1:15
r4
:
The form of the resulting relationship was that the cap-
illary pressure increased almost linearly from DBP =
125 mmHg to a peak value of 42 mmHg at DBP =
60 mmHg after which it declined linearly as the DBP
continued to fall (Fig. 6B). Transformation of the hydro-
static pressure into net fluid flux was made on the follow-
ing basis. In the rat mesenteric bed, the hydrostatic
pressure at the arteriolar end has been reported to be
22 mmHg and 12.5 mmHg at the venous end, whereas
the oncotic pressure varies between 16 and 21 mmHg
along the length of the capillary bed (Landis and Pappen-
heimer 1963). It was assumed that, at an arteriolar pres-
sure of 22 mmHg, the Starling forces are in balance and
no net fluid flux occurs. As the excess between this value
and the peak capillary pressure value of 42 mmHg
(Fig. 6B) leads to exudation of fluid at a projected rate of
+20 lL cm1 h1 (Fig. 2), this gives a filtration constant
of 1.0 lL cm1 h1 mmHg1 which then must be multi-
plied by a factor for the changing surface area (2prl)
which is taken to be proportional to r, thus giving a fil-
tration coefficient of 1.0 r. The outcome for the projected
rate of fluid secretion/absorption is shown in Figure 6C;
so, at high and low DBP, there is fluid absorption while,
in the zone of DBP from 100 to 30 mmHg, there is secre-
tion with the peak secretion at 60 mmHg. The agreement
between the calculated curve with the data points trans-
ferred from Figure 2 is remarkably good (R2 = 68%,
P < 0.001) and goes some way to supporting the plausi-
bility of the proposed process for intestinal fluid secre-
tion.
Relevance to secretory diarrhea
The applicability of the present results which indicate a
role for filtration of fluid from the mucosal capillary bed
as a consequence of increased capillary pressure needs to
be considered in the context of toxins reported to cause
secretory diarrhea.
Previous results in vivo have indicated that, while
E. coli STa toxin reduced absorption, it did not promote
active secretion of fluid into the jejunum (Sach et al.
1976; Rolfe and Levin 1994; Lucas et al. 2005, 2008,
2011). This result was confirmed in additional studies on
three animals in which absorption of fluid from a Krebs-
glucose perfusate was reduced from 89 to +1.9 lL
cm1 h1. It was also clear that perfusion of the jejunum
with STa toxin was without effect on the DBP which was
shown in five experiments (P = 0.29) (Fig. 7), which is
in marked contrast to the effects of V. cholerae toxin.
When this was administered to conscious/lightly anesthe-
tized dogs, there was fluid loss from the rectum of one
liter over the first 5 h, which was preceded by a decline
in mean ABP from 100 mmHg down to 30 mmHg and
by an increase in superior mesenteric blood flow (Car-
penter et al. 1969). A similar result has also been
reported in anesthetized cats with the additional finding
that the reduced ABP and increased mucosal blood flow
may arise by stimulation of VIP release from intestinal
neurones by the cholera toxin (Cassuto et al. 1981). At
the histological level, increased blood flow was also evi-
dent after exposure to V. cholerae toxin, as shown by villi
which were congested with edema and blood which had
entered through increased gaps between capillary endo-
thelial cells (Patnaik and Ghosh 1966; Lee 1977) and by
distended mucosal vasculature and lymphatic vessels
(Norris et al. 1967). Further evidence relating to the
importance of blood flow in cholera-induced secretion
comes from the experiments of Strombeck (1972) who
induced intestinal secretions with V. cholerae toxin
in vivo; however, once the intestinal loops had been
excised and mounted in vitro, the secretions abated and
normal absorption ensued. Hence, these results demon-
strate that secretion is only convincingly detected in the
presence of an intact vasculature and appropriate pres-
sure gradient. The extent to which these results from
studies on animal models can be related to the human
condition is, however, restricted by the dearth of human
ABP data and the fact that fluid loss per se is treated by
oral and I.V. fluid transfusions. There are studies on
human volunteers in whom ABP was reported to remain
constant though the toxin was delivered in small amounts
into a restricted length of jejunum (Petritsch et al. 1992).
By contrast, hospital patients with acute phase cholera
are always reported to be markedly hypotensive (Rogers
1909; Carpenter et al. 1961) with the ABP as low as
54 mmHg (Banwell et al. 1970). It is noteworthy that
newly admitted patients who received three times the
normal I.V. infusion made a remarkable recovery com-
pared with those who received the standard infusion
(Carpenter et al. 1961), though whether intestinal fluid
Figure 7. Effect of addition of 40 ng mL1 STa toxin to jejunal
Krebs-glucose perfusate (STa) on ABP. The dashed horizontal line
denotes 0 mmHg.
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loss had abated was not reported. On balance, the
results point toward the importance of ABP in cholera-
induced secretory diarrhea and the basis for this may
reside in the increased capillary filtration arising from
increased capillary pressure. Whether this also holds for
secretory diarrhea caused by the E. coli toxins remains
an open question, though the absence of an action
of E. coli STa toxin on ABP in animal experiments
would account for the absence of net secretion in these
experiments.
In conclusion, our results strongly suggest that at least
a major component of the secretory response in secretory
diarrhea has a vascular origin due to the systemic effect
of V. cholerae toxin causing systemic vasodilatation and
consequently increasing mucosal capillary pressure to
cause exudation of fluid. However, there has to be a rec-
ognition that our conclusion is based on inferences about
capillary pressure which remains to be measured directly
during exposure to V. cholerae toxin and that our results
pertain to the rat model, whereas validation in a large
animal model would be desirable. While methodologi-
cally, this will require further technically demanding
experiments, there is a parallel direction in which work
could proceed: this would be to explore the efficacy of
administration of a specific vasoconstrictor agent devoid
of cardiac actions to test the effects of restoration of the
ABP during exposure to V. cholerae toxin. While we have
already demonstrated that vasopressin I.V. promotes
absorption (Fig. 2), there is a more specific vasopressor
agent such as felypressin, a synthetic analog of vasopres-
sin, which acts more specifically on the vasculature and
has a reduced antidiuretic action (Martindale, 2011). This
and other vasopressin analogs may be a future avenue for
a possible therapeutic intervention in the clinical manage-
ment of secretory diarrhea.
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Appendix
P and p are the hydrostatic and oncotic pressures, respec-
tively, in the capillary (c), interstitial fluid (i), and lumi-
nal (l) compartments. Jci is the flux from capillaries to
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interstitial fluid, Jil is the flux from interstitial fluid to
lumen, Kci is the filtration coefficient between the capil-
laries and interstitial fluid, and Kil is the filtration coeffi-
cient between the interstitial fluid and lumen. The value
of Kci obtained for cat mesenteric capillaries of
125 lL h1 mmHg1 g1 (Granger et al. 1979) far
exceeds the value of Kil of 9.4 lL h
1 mmHg1 g1
obtained as the negative slope in Figure 2, converted to
units per gram weight. The reflection coefficients (r) have
been set to unity (Granger et al. 1979). The fluxes
between the compartments are as follows (Taylor 1981):
Jci ¼ KcifðPc  pcÞ  ðPi  piÞg
Jil ¼ KilfðPi  piÞ  ðPl  plÞg
Since Pl & pi are zero
Jil ¼ KilðPi  piÞ
At steady state Jci ¼ Jil
KcifðPc  pcÞ  ðPi  piÞg ¼ KilðPi  piÞ
KciðPc  pcÞ ¼ ðKci þ KilÞðPi  piÞ
ðPc  pcÞ ¼ ðKci þ KilÞ
Kci
ðPi  piÞ
Since Kci  Kil; ðKci þ KilÞ
Kci
! 1
ðPc  pcÞ ¼ ðPi  piÞ
Jil ¼ KilðPc  pcÞ
Thus, the flow of fluid from capillaries into the lumen
is mainly determined by the capillary hydrostatic and
oncotic pressure difference and the filtration coefficient
between the interstitial fluid and lumen.
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